These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Orphan products: drugs and devices for rare diseases. Pillar B Nurs Econ; 1993; 11(2):99-102. PubMed ID: 8502310 [TBL] [Abstract][Full Text] [Related]
3. Orphan drug development in the United States. Groft SC CPJ; 1985 May; 118(5):219-22. PubMed ID: 10271306 [TBL] [Abstract][Full Text] [Related]
4. The role of voluntary disease organizations in research and development of orphan drugs. Horansky R Prog Clin Biol Res; 1985; 197():179-81. PubMed ID: 4070293 [No Abstract] [Full Text] [Related]
5. Orphan Drug Act on congressional agenda. von Oehsen WH Physician Exec; 1989; 15(3):34-5. PubMed ID: 10313123 [TBL] [Abstract][Full Text] [Related]
6. Orphan Drugs Information Center. FDA Drug Bull; 1985 Apr; 15(1):9-10. PubMed ID: 3996806 [No Abstract] [Full Text] [Related]
7. The development of orphan drugs--a pharmaceutical company perspective. Stucki JC Prog Clin Biol Res; 1985; 197():95-104. PubMed ID: 4070303 [No Abstract] [Full Text] [Related]
8. Problems associated with developing orphan drugs into available therapy. Van Woert MH Prog Clin Biol Res; 1985; 197():171-3. PubMed ID: 4070291 [No Abstract] [Full Text] [Related]
9. Orphan drugs. Improved medical treatment of rare diseases. Cramer R Ala J Med Sci; 1988 Jul; 25(3):257-67. PubMed ID: 3052135 [No Abstract] [Full Text] [Related]
10. Rare diseases: identifying needs. Report of the National Commission on Orphan Diseases. Groft SC Am Pharm; 1990 Apr; NS30(4):33-40. PubMed ID: 2321528 [No Abstract] [Full Text] [Related]
11. Cooperative approaches to research and development of orphan drugs. Proceedings of a conference. New York, New York, April 9 and 10, 1984. Prog Clin Biol Res; 1985; 197():1-204. PubMed ID: 4070283 [No Abstract] [Full Text] [Related]
12. [Orphan drugs]. Kolár J; Chalabala M; Srámková H Ceska Slov Farm; 2001 Mar; 50(2):59-65. PubMed ID: 11288591 [TBL] [Abstract][Full Text] [Related]
13. The fuel to run the orphan drug engine: a medical school-based Orphan Disease Center Program. Brewer GJ Prog Clin Biol Res; 1985; 197():123-38. PubMed ID: 4070287 [No Abstract] [Full Text] [Related]
14. The Pharmaceutical Manufacturers Association Commission on Drugs for Rare Diseases. Goldstein GS Prog Clin Biol Res; 1985; 197():35-9. PubMed ID: 4070297 [No Abstract] [Full Text] [Related]